Home/ Stocks/ BBLG

Bone Biologics Corp Common Stock

BBLG XNAS

$0.93 +0.01 (+1.42%) ▲ 15-min delayed

Open

$0.99

High

$0.99

Low

$0.89

Volume

35.1K

Market Cap

$1.66M

About Bone Biologics Corp Common Stock

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Sector: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES Employees: 2 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-800,000	$-0.43
FY 2025	$0	$-3,100,000	$-2.65
Q3 2025	$0	$-666,737	$-0.37
Q2 2025	$0	$-740,519	$-1.33

Related Market News

No specific coverage for BBLG yet. Check out our latest market news or earnings calendar.

Get BBLG Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Bone Biologics Corp Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.